POST SUMMARY: There can be no doubt that changes are needed within biopharma DTC marketing to ensure that marketing to patients and consumers remains relevant.  However, as long as antiquated hiring practices and rebels are denied entry into DTC marketing the industry is doomed to see budgets cut further as senior management looks to cut costs.